Table 1.
Molecular marker | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Stagea | PTUb | nkx2.1a | hhex | pax2a | pax8 | foxe1 | tg | tpo | slc5a5 | iyd | bcl2l1 |
55 hpf | None | 37%c | 41% | 28% | 42% | 39% | 51% | 44% | 59% | 49% | 40% |
25/68d | 24/58 | 21/74 | 31/73 | 21/54 | 31/61 | 33/75 | 41/69 | 37/75 | 23/57 | ||
0.003% | 42% | 39% | 31% | 40% | 40% | 48% | 55% | 71% | 58% | 36% | |
33/77 | 24/61 | 20/64 | 22/55 | 24/60 | 30/62 | 34/62 | 52/73 | 38/65 | 24/67 | ||
100 hpf | None | 100% | 46% | n.q.e | 78% | n.d.f | 31% | 100% | 100% | 100% | n.d. |
78/78 | 29/63 | 51/65 | 20/64 | 84/84 | 81/81 | 74/74 | |||||
0.003% | 99% | 81% | n.q. | 97% | n.d. | 61% | 100% | 100% | 100% | n.d. | |
70/71 | 48/59 | 59/61 | 46/76 | 78/78 | 76/76 | 72/72 |
Staining characteristics of thyroid tissue were compared between embryos injected with 2.5 ng tshr-MO or equimolar amounts of standard control MO. Sample size in the control group was n = 57–81 embryos per gene and time point. All analyses were performed with casper embryos. n.q., Not quantified; n.d., not detectable.
Developmental stage in hpf at which embryos were sampled and fixed for analyses.
Analyses were performed for embryos raised in the absence or presence of 0.003% PTU in embryo medium.
Percentage of tshr morphants displaying reduced expression of a given thyroid marker.
Number of tshr morphants displaying reduced expression/total number of tshr morphants analyzed.
Effects not quantified (n.q.) due to very low or absent staining in control larvae at 100 hpf.
Expression not detectable (n.d.) in thyroid of tshr morphants and control larvae at 100 hpf.